Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Toxicology and Applied Pharmacology
|
March 14, 1998
Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the toxic oil syndrome
C Berking, M V Hobbs, R Chatelain, et al.
Acta Endocrinologica
|
November 1, 1984
Effects of continuous infusions of 4-hydroxyoestradiol and oestradiol on plasma LH-levels in the ovariectomized ewe
G Emons, C Brack, R Chatelain, et al.
Annales De Microbiologie
|
January 1, 1975
[Isolation of "Brucella suis" biotype 5 from a bitch, in Madagascar. Validity of the species name "Brucella canis" (author's transl)]
J M Verger, M Gâté, M Piéchaud, et al.
Archives Francaises De Pediatrie
|
November 1, 1979
[Septic arthritis due to a nontoxigenic diphtheria bacillus]
P Guran, H H Mollaret, R Chatelain, et al.
Analytical and Quantitative Cytology and Histology
|
April 1, 1989
DNA grading of malignancy in breast cancer. Prognostic validity, reproducibility and comparison with other classifications
A Böcking, R Chatelain, S Biesterfeld, et al.
Anticancer Research
|
March 1, 1991
Detection of high risk patients in chronic myelogenous leukemia by DNA-image cytometry
C P Muller, M Kropff, S Biesterfeld, et al.
Archives of Dermatological Research
|
November 10, 1998
IL-10 inhibits ICAM-1 expression on human Langerhans cells but not on keratinocytes, dermal endothelial cells or fibroblasts
R Chatelain, A Wollenberg, C Martin, et al.
Analytical and Quantitative Cytology and Histology
|
December 1, 1991
Monitoring DNA cytometric parameters during the course of chronic myelogenous leukemia
M Kropff, R Chatelain, C P Muller, et al.
Anticancer Research
|
September 1, 1986
DNA-grading of malignant lymphomas. I. Prognostic significance, reproducibility and comparison with other classifications
A Böcking, R Chatelain, W Auffermann, et al.
Anticancer Research
|
September 1, 1986
DNA-grading of malignant lymphomas. II. Correlation with clinical parameters
A Böcking, R Chatelain, W Auffermann, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Toxicology and Applied Pharmacology
|
March 14, 1998
Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the toxic oil syndrome
C Berking, M V Hobbs, R Chatelain, et al.
Acta Endocrinologica
|
November 1, 1984
Effects of continuous infusions of 4-hydroxyoestradiol and oestradiol on plasma LH-levels in the ovariectomized ewe
G Emons, C Brack, R Chatelain, et al.
Annales De Microbiologie
|
January 1, 1975
[Isolation of "Brucella suis" biotype 5 from a bitch, in Madagascar. Validity of the species name "Brucella canis" (author's transl)]
J M Verger, M Gâté, M Piéchaud, et al.
Archives Francaises De Pediatrie
|
November 1, 1979
[Septic arthritis due to a nontoxigenic diphtheria bacillus]
P Guran, H H Mollaret, R Chatelain, et al.
Analytical and Quantitative Cytology and Histology
|
April 1, 1989
DNA grading of malignancy in breast cancer. Prognostic validity, reproducibility and comparison with other classifications
A Böcking, R Chatelain, S Biesterfeld, et al.
Anticancer Research
|
March 1, 1991
Detection of high risk patients in chronic myelogenous leukemia by DNA-image cytometry
C P Muller, M Kropff, S Biesterfeld, et al.
Archives of Dermatological Research
|
November 10, 1998
IL-10 inhibits ICAM-1 expression on human Langerhans cells but not on keratinocytes, dermal endothelial cells or fibroblasts
R Chatelain, A Wollenberg, C Martin, et al.
Analytical and Quantitative Cytology and Histology
|
December 1, 1991
Monitoring DNA cytometric parameters during the course of chronic myelogenous leukemia
M Kropff, R Chatelain, C P Muller, et al.
Anticancer Research
|
September 1, 1986
DNA-grading of malignant lymphomas. I. Prognostic significance, reproducibility and comparison with other classifications
A Böcking, R Chatelain, W Auffermann, et al.
Anticancer Research
|
September 1, 1986
DNA-grading of malignant lymphomas. II. Correlation with clinical parameters
A Böcking, R Chatelain, W Auffermann, et al.
Page
of 5